Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortality

British Journal of Haematology

Volumn 156, Issue 1, 2012, Pages 99-108

  George, Diane ^a   El Mallawany, Nader Kim ^a   Jin, Zhezhen ^a   Geyer, Mark ^a   Della Latta, Phyllis ^a   Satwani, Prakash ^a   Garvin, James H ^a   Bradley, Mary Brigid ^a   Bhatia, Monica ^a   van de Ven, Carmella ^a   Morris, Erin ^a   Schwartz, Joseph ^a   Cairo, Mitchell S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adenovirus; Allogeneic stem cell transplantation; Paediatrics; Risk factors; Unrelated donor transplant

Indexed keywords

ALEMTUZUMAB; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADENOVIRUS; ADENOVIRUS INFECTION; ADOLESCENT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DRUG USE; FEMALE; GRAFT RECIPIENT; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; OVERALL SURVIVAL; PEDIATRICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VIRUS ISOLATION;

ADENOVIRIDAE INFECTIONS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; RISK ASSESSMENT; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 83555166294     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08468.x     Document Type: Article

References (42)

1. Baldwin, A., Kingman, H., Darville, M., Foot, A.B., Grier, D., Cornish, J.M., Goulden, N., Oakhill, A., Pamphilon, D.H., Steward, C.G. & Marks, D.I. (2000) Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplantation, 26, 1333-1338.
2. Bhatia, M., Militano, O., Jin, Z., Figurski, M., Shaw, L., Moore, V., Morris, E., Tallamy, B., van deVen, C., Ayello, J., Baxter-Lowe, L., Satwani, P., George, D., Bradley, M.B., Garvin, J. & Cairo, M.S. (2010) An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biology of Blood and Marrow Transplantation, 16, 333-343.
3. Blanke, C., Clark, C., Broun, E.R., Tricot, G., Cunningham, I., Cornetta, K., Hedderman, A. & Hromas, R. (1995) Evolving pathogens in allogeneic bone marrow transplantation: increased fatal adenoviral infections. American Journal of Medicine, 99, 326-328.
4. Bruno, B., Gooley, T., Hackman, R.C., Davis, C., Corey, L. & Boeckh, M. (2003) Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biology of Blood and Marrow Transplantation, 9, 341-352.
5. Chakrabarti, S., Collingham, K.E., Fegan, C.D., Pillay, D. & Milligan, D.W. (2000) Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? Bone Marrow Transplantation, 26, 305-307.
6. Chakrabarti, S., Mautner, V., Osman, H., Collingham, K.E., Fegan, C.D., Klapper, P.E., Moss, P.A. & Milligan, D.W. (2002) Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood, 100, 1619-1627.
7. Chatziandreou, I., Gilmour, K.C., McNicol, A.M., Costabile, M., Sinclair, J., Cubitt, D., Campbell, J.D., Kinnon, C., Qasim, W. & Gaspar, H.B. (2007) Capture and generation of adenovirus specific T cells for adoptive immunotherapy. British Journal of Haematology, 136, 117-126.
8. Echavarria, M. (2008) Adenoviruses in immunocompromised hosts. Clinical Microbiology Reviews, 21, 704-715.
9. Echavarria, M., Forman, M., van Tol, M.J., Vossen, J.M., Charache, P. & Kroes, A.C. (2001) Prediction of severe disseminated adenovirus infection by serum PCR. Lancet, 358, 384-385.
10. Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C., Schuster, F.R., Beck, R., Schumm, M., Lotfi, R., Jahn, G. & Lang, P. (2006) Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology, 134, 64-76.
11. Feuchtinger, T., Lang, P. & Handgretinger, R. (2007) Adenovirus infection after allogeneic stem cell transplantation. Leukaemia & Lymphoma, 48, 244-255.
12. Feuchtinger, T., Richard, C., Joachim, S., Scheible, M.H., Schumm, M., Hamprecht, K., Martin, D., Jahn, G., Handgretinger, R. & Lang, P. (2008) Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. Journal of Immunotherapy, 31, 199-206.
13. Flomenberg, P., Babbitt, J., Drobyski, W.R., Ash, R.C., Carrigan, D.R., Sedmak, G.V., McAuliffe, T., Camitta, B., Horowitz, M.M., Bunin, N. & Casper, J.T. (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Diseases, 169, 775-781.
14. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. & Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295-304.
15. Hale, G.A., Heslop, H.E., Krance, R.A., Brenner, M.A., Jayawardene, D., Srivastava, D.K. & Patrick, C.C. (1999) Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplantation, 23, 277-282.
16. Hoffman, J.A., Shah, A.J., Ross, L.A. & Kapoor, N. (2001) Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 7, 388-394.
17. Kim, D.H., Kim, J.G., Sohn, S.K., Sung, W.J., Suh, J.S., Lee, K.S. & Lee, K.B. (2004) Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. British Journal of Haematology, 125, 217-224.
18. Krilov, L.R. (2005) Adenovirus infections in the immunocompromised host. Pediatric Infectious Disease Journal, 24, 555-556.
19. Lankester, A.C., van Tol, M.J., Claas, E.C., Vossen, J.M. & Kroes, A.C. (2002) Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clinical Infectious Diseases, 34, 864-867.
20. Leen, A.M., Myers, G.D., Bollard, C.M., Huls, M.H., Sili, U., Gee, A.P., Heslop, H.E. & Rooney, C.M. (2005) T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Annals of the New York Academy of Sciences, 1062, 104-115.
21. Leen, A.M., Bollard, C.M., Myers, G.D. & Rooney, C.M. (2006) Adenoviral infections in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 243-251.
22. Leen, A.M., Christin, A., Myers, G.D., Liu, H., Cruz, C.R., Hanley, P.J., Kennedy-Nasser, A.A., Leung, K.S., Gee, A.P., Krance, R.A., Brenner, M.K., Heslop, H.E., Rooney, C.M. & Bollard, C.M. (2009) Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplant. Blood, 114, 4283-4292.
23. Lion, T., Baumgartinger, R., Watzinger, F., Matthes-Martin, S., Suda, M., Preuner, S., Futterknecht, B., Lawitschka, A., Peters, C., Potschger, U. & Gadner, H. (2003) Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, 102, 1114-1120.
24. Ljungman, P. (2004) Treatment of adenovirus infections in the immunocompromised host. European Journal of Clinical Microbiology and Infectious Diseases, 23, 583-588.
25. Ljungman, P., Ribaud, P., Eyrich, M., Matthes-Martin, S., Einsele, H., Bleakley, M., Machaczka, M., Bierings, M., Bosi, A., Gratecos, N. & Cordonnier, C. (2003) Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 31, 481-486.
26. Myers, G.D., Krance, R.A., Weiss, H., Kuehnle, I., Demmler, G., Heslop, H.E. & Bollard, C.M. (2005) Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplantation, 36, 1001-1008.
27. Myers, G.D., Bollard, C.M., Wu, M.F., Weiss, H., Rooney, C.M., Heslop, H.E. & Leen, A.M. (2007) Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplantation, 39, 677-686.
28. Neofytos, D., Ojha, A., Mookerjee, B., Wagner, J., Filicko, J., Ferber, A., Dessain, S., Grosso, D., Brunner, J., Flomenberg, N. & Flomenberg, P. (2007) Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biology of Blood and Marrow Transplantation, 13, 74-81.
29. Osunkwo, I., Bessmertny, O., Harrison, L., Cheung, Y.K., Van de Ven, C., del Toro, G., Garvin, J., George, D., Bradley, M.B., Wolownik, K., Wischhover, C., Levy, J., Skerrett, D. & Cairo, M.S. (2004) A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Biology of Blood and Marrow Transplantation, 10, 246-258.
30. Pring-Akerblom, P., Trijssenaar, F.E., Adrian, T. & Hoyer, H. (1999) Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples. Journal of Medical Virology, 58, 87-92.
31. Robin, M., Marque-Juillet, S., Scieux, C., Peffault de Latour, R., Ferry, C., Rocha, V., Molina, J.M., Bergeron, A., Devergie, A., Gluckman, E., Ribaud, P. & Socie, G. (2007) Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica, 92, 1254-1257.
32. Rocholl, C., Gerber, K., Daly, J., Pavia, A.T. & Byington, C.L. (2004) Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics, 113, e51-e56.
33. Roman, E., Osunkwo, I., Militano, O., Cooney, E., van de Ven, C. & Cairo, M.S. (2008) Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation. Pediatric Blood & Cancer, 50, 325-330.
34. Runde, V., Ross, S., Trenschel, R., Lagemann, E., Basu, O., Renzing-Kohler, K., Schaefer, U.W., Roggendorf, M. & Holler, E. (2001) Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplantation, 28, 51-57.
35. Savani, B.N., Mielke, S., Rezvani, K., Montero, A., Yong, A.S., Wish, L., Superata, J., Kurlander, R., Singh, A., Childs, R. & Barrett, A.J. (2007) Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 1216-1223.
36. Shereck, E.B., Cooney, E., van de Ven, C., Della-Lotta, P. & Cairo, M.S. (2007) A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatric Blood & Cancer, 49, 306-312.
37. Sivaprakasam, P., Carr, T.F., Coussons, M., Khalid, T., Bailey, A.S., Guiver, M., Mutton, K.J., Turner, A.J., Grainger, J.D. & Wynn, R.F. (2007) Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. Journal of Pediatric Hematology/oncology, 29, 81-85.
38. van Tol, M.J., Kroes, A.C., Schinkel, J., Dinkelaar, W., Claas, E.C., Jol-van der Zijde, C.M. & Vossen, J.M. (2005) Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplantation, 36, 39-50.
39. Walls, T., Shankar, A.G. & Shingadia, D. (2003) Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. The Lancet Infectious Diseases, 3, 79-86.
40. Waxman, I.M., Militano, O., Baldinger, L., Roman, E., Qualter, E., Morris, E., Garvin, J., Bradley, M.B., Bhatia, M., Satwani, P., George, D., Del Toro, G., Hawks, R., Wolownik, K., Foley, S., Cheung, Y.K., Schwartz, J., van de Ven, C., Baxter-Lowe, L.A. & Cairo, M.S. (2009) Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning. Pediatric Transplantation, 13, 464-474.
41. Xu, W., McDonough, M.C. & Erdman, D.D. (2000) Species-specific identification of human adenoviruses by a multiplex PCR assay. Journal of Clinical Microbiology, 38, 4114-4120.
42. Yusuf, U., Hale, G.A., Carr, J., Gu, Z., Benaim, E., Woodard, P., Kasow, K.A., Horwitz, E.M., Leung, W., Srivastava, D.K., Handgretinger, R. & Hayden, R.T. (2006) Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation, 81, 1398-1404.